PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE

The present disclosure relates to HIF-1alpha prolyl hydroxylase inhibitors, compositions which comprise the HIF-1alpha prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	WU SHENGDE, EVDOKIMOV ARTEM G, BOYER ANGELIQUE SUN, WARSHAKOON NAMAL C, KAWAMOTO RICHARD MASARU, GREIS KENNETH D
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	WU SHENGDE EVDOKIMOV ARTEM G BOYER ANGELIQUE SUN WARSHAKOON NAMAL C KAWAMOTO RICHARD MASARU GREIS KENNETH D
description	The present disclosure relates to HIF-1alpha prolyl hydroxylase inhibitors, compositions which comprise the HIF-1alpha prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2013203816A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2013203816A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2013203816A13</originalsourceid><addsrcrecordid>eNrjZDAICPL3ifRR8Ih0CfKPiPRxDHZV8PTz8HTyDPEPClZw9HNR8HUN8fB3CVbwd1MIDXblYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBobGRgbGFoZmjobGxKkCAOY0J2E</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE</title><source>esp@cenet</source><creator>WU SHENGDE ; EVDOKIMOV ARTEM G ; BOYER ANGELIQUE SUN ; WARSHAKOON NAMAL C ; KAWAMOTO RICHARD MASARU ; GREIS KENNETH D</creator><creatorcontrib>WU SHENGDE ; EVDOKIMOV ARTEM G ; BOYER ANGELIQUE SUN ; WARSHAKOON NAMAL C ; KAWAMOTO RICHARD MASARU ; GREIS KENNETH D</creatorcontrib><description>The present disclosure relates to HIF-1alpha prolyl hydroxylase inhibitors, compositions which comprise the HIF-1alpha prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2013</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130808&DB=EPODOC&CC=US&NR=2013203816A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130808&DB=EPODOC&CC=US&NR=2013203816A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WU SHENGDE</creatorcontrib><creatorcontrib>EVDOKIMOV ARTEM G</creatorcontrib><creatorcontrib>BOYER ANGELIQUE SUN</creatorcontrib><creatorcontrib>WARSHAKOON NAMAL C</creatorcontrib><creatorcontrib>KAWAMOTO RICHARD MASARU</creatorcontrib><creatorcontrib>GREIS KENNETH D</creatorcontrib><title>PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE</title><description>The present disclosure relates to HIF-1alpha prolyl hydroxylase inhibitors, compositions which comprise the HIF-1alpha prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2013</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAICPL3ifRR8Ih0CfKPiPRxDHZV8PTz8HTyDPEPClZw9HNR8HUN8fB3CVbwd1MIDXblYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBobGRgbGFoZmjobGxKkCAOY0J2E</recordid><startdate>20130808</startdate><enddate>20130808</enddate><creator>WU SHENGDE</creator><creator>EVDOKIMOV ARTEM G</creator><creator>BOYER ANGELIQUE SUN</creator><creator>WARSHAKOON NAMAL C</creator><creator>KAWAMOTO RICHARD MASARU</creator><creator>GREIS KENNETH D</creator><scope>EVB</scope></search><sort><creationdate>20130808</creationdate><title>PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE</title><author>WU SHENGDE ; EVDOKIMOV ARTEM G ; BOYER ANGELIQUE SUN ; WARSHAKOON NAMAL C ; KAWAMOTO RICHARD MASARU ; GREIS KENNETH D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2013203816A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2013</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>WU SHENGDE</creatorcontrib><creatorcontrib>EVDOKIMOV ARTEM G</creatorcontrib><creatorcontrib>BOYER ANGELIQUE SUN</creatorcontrib><creatorcontrib>WARSHAKOON NAMAL C</creatorcontrib><creatorcontrib>KAWAMOTO RICHARD MASARU</creatorcontrib><creatorcontrib>GREIS KENNETH D</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WU SHENGDE</au><au>EVDOKIMOV ARTEM G</au><au>BOYER ANGELIQUE SUN</au><au>WARSHAKOON NAMAL C</au><au>KAWAMOTO RICHARD MASARU</au><au>GREIS KENNETH D</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE</title><date>2013-08-08</date><risdate>2013</risdate><abstract>The present disclosure relates to HIF-1alpha prolyl hydroxylase inhibitors, compositions which comprise the HIF-1alpha prolyl hydroxylase inhibitors described herein and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_epo_espacenet_US2013203816A1
source	esp@cenet
subjects	CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY
title	PROLYL HYDROXYLASE INHIBITORS AND METHODS OF USE
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T20%3A21%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WU%20SHENGDE&rft.date=2013-08-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2013203816A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true